Background Whether inhaled corticosteroids (ICSs) reduce major adverse cardiovascular events (MACEs) in people with chronic obstructive pulmonary disease (COPD) is debated. Objectives To establish, ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD).

Children who start smoking prior to age 15 have a 27% increased risk of developing chronic obstructive pulmonary disease (COPD) as adults, compared to those who started smoking later, researchers ...

He has participated on advisory boards for Novartis, Promethera, Sequana, Gilead and Martin Pharmaceuticals. Provenance and peer review Not commissioned; externally peer reviewed. Supplemental ...

Study finds physical activity reduces chronic disease risk Researchers recommend health care providers survey patients on physical activity levels Date: January 2, 2025 Source: University of Iowa ...

COPD Chronic Obstructive Pulmonary Disease is a group of long term lung diseases which make it difficult to breathe and is often a mix of emphysema and chronic bronchitis It is the third leading ...

A NEW study has revealed that patients from socioeconomically disadvantaged neighborhoods are less likely to receive guideline-recommended follow-up care for incidentally detected pulmonary nodules, ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity. This ...

Patients with COPD who also had prior asthma diagnoses were included in ... interpretation, of the data; review, or approval of the manuscript; and decision to submit the manuscript for publication.